Assessment of the effects of naringenin-type flavanones in uterus and vagina
- 1 January 2015
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 145, 49-57
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft DFG (KR 3768/2-1)
This publication has 63 references indexed in Scilit:
- The pros and cons of plant estrogens for menopauseThe Journal of Steroid Biochemistry and Molecular Biology, 2014
- Phytoestrogens for menopausal bone loss and climacteric symptomsThe Journal of Steroid Biochemistry and Molecular Biology, 2014
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsJAMA, 2013
- MenopauseThe Lancet, 2008
- Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic ProceduresThe Women's Health Initiative Randomized TrialJAMA, 2003
- Phytoestrogens: a review of the present state of researchPhytotherapy Research, 2003
- Evidence from randomised trials on the long-term effects of hormone replacement therapyThe Lancet, 2002
- Estrogenic Activity of the Phytoestrogens Naringenin, 6-(1,1-Dimethylallyl)naringenin and 8-PrenylnaringeninPlanta Medica, 2002
- Bioavailability of the flavanone naringenin and its glycosides in ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2000
- Naringenin: A weakly estrogenic bioflavonoid that exhibits antiestrogenic activityBiochemical Pharmacology, 1995